Exisulind (tentative trade name Aptosyn) is an antineoplastic agent. It acts by inhibiting the enzyme cyclic guanosine monophosphate phosphodiesterase type 5 (). It is the sulfone derivative of sulindac, an NSAID.
Exisulind (tentative trade name Aptosyn) is an antineoplastic agent that works by inhibiting the enzyme cyclic guanosine monophosphate phosphodiesterase type 5. It is derived from sulindac, a non-steroidal anti-inflammatory drug (NSAID).